25-28 May 2016 Montpellier
![]() |
![]() |
![]() |
![]() |
0-VWF | Structure and mechanics of von Willebrand factor are regulated by pH-dependent interactions in dimeric subunits | Jochen P. Mller | ![]() |
![]() |
|||
1-LUP | Inverted Erythrocyte Membranes as a Novel Model for Studying the Antiphospholipid Syndrome | Saartje Bloemen | ![]() |
![]() |
|||
1-WOR | Absence of Pre-Operative VWF Workup is Associated with Increased Intraoperative Bleeding during Wilms Tumor Resection | Shiu-Ki Hui | ![]() |
![]() |
|||
1-GEN | Diagnosis of Inherited Platelet Disorders by a Panel-Based Next Generation Sequencing Approach | Harald Schulze | ![]() |
![]() |
|||
1-BR | Microfluidic Platform for Automated Endothelial Cell Culture Enabling Real Time Visualisation of Blood Cell Function under Flow | Crispin Szydzik | ![]() |
![]() |
|||
1-HEM | The anti-cancer action of high versus low doses aspirin | Annachiara Mitrugno | ![]() |
![]() |
|||
1-VWF | Blood Outgrowth Endothelial Cells from Type 3 von Willebrand Disease Patients Display Abnormal Angiogenesis | Soundarya Selvam | ![]() |
![]() |
|||
1-DIC | Porcine Model of Methicillin-resistant Staphylococcus Aureus (MRSA) Sepsis-induced Disseminated Intravascular Coagulation (DIC) | Trung Nguyen | ![]() |
![]() |
|||
1-PLA | HIF-2a Downregulates Tissue Factor Pathway inhibitor Expression in Breast Cancer | Xue Yan Cui | ![]() |
![]() |
|||
1-FIB | Hyaluronic Acid Decreases the Mechanical Stability, but Increases the Lytic Resistance of Fibrin | Keasimir Kolev | ![]() |
![]() |
|||
1-FVIII | INSIGHT Case-Control Study: High FVIII Concentrate Dose and Surgery Are Associated with Increased Inhibitor Risk in Nonsevere Hemophilia A Patients | Karin Fijnvandraat | ![]() |
![]() |
|||
1-FXI | Novel Mechanisms Regulating Factor XI Plasma Levels | Maria Sabater-Lleal | ![]() |
![]() |
|||
1-PRE | Transient Impact of Treatment Exposures and One-year Incidence of Thrombosis in Multiple Myeloma: A Case-time-Control Analysis | Joshua Brown | ![]() |
![]() |
|||
1-WOM | Phenotype of Congenital Factor XIII Deficiency in Women: Report of the French Cohort | Christophe Martinaud | ![]() |
![]() |
|||
2-FXIII | Structure and Function Consequences of a Novel Missense Mutation in FGB Gene (Bbeta Gly272Arg/p.Gly302Arg) Resulting in Afibrinogenemia | German Detarsio | ![]() |
![]() |
|||
2-GEN02 | Design and Application of a Twenty-Three-Gene Panel by Next-Generation Sequencing for Inherited Coagulation Bleeding Disorders | JOSE MARIA BASTIDA | ![]() |
![]() |
|||
2-PP | Defects in TRPM7 Channel Function Deregulate Thrombopoiesis through Altered Cellular Mg2 Homeostasis and Cytoskeletal Architecture | Simon Stritt | ![]() |
![]() |
|||
2-LUP | Pravastatin Ameliorates Preeclampsia and/or Severe IUGR in 13 Women with Refractory Obstetric Antiphospholipid Syndrome (APS) | Eleftheria Lefkou | ![]() |
![]() |
|||
2-WOR | High Variation of Peri-Operative Bridging Use in Real-World Practice: Results from a Clinician Survey | Geoffrey Barnes | ![]() |
![]() |
|||
2-VWF | Inhibition of vWF Secretion with Novel Galpha 12 N-terminal alpha-SNAP Binding Domain Peptide Increases Survival in Septic Mice | Luiza Rusu | ![]() |
![]() |
|||
2-WOM | Abnormal Platelet GPIba and Pregnancy Outcome: An Exploratory Study | Maha Othman | ![]() |
![]() |
|||
2-HEM | Platelets Upregulate c-MYC Oncoprotein in Pancreatic Cancer Cells: Potential Mechanism of Platelet-Driven Neoplastic Proliferation | Annachiara Mitrugno | ![]() |
![]() |
|||
2-PED | Characterization of Laboratory Coagulation Parameters and Risk Factors for Intraventricular Hemorrhage (IVH) in Extremely Premature Neonates | Jonathan Roberts | ![]() |
![]() |
|||
2-PLA | Antithrombin Resistance Caused by c.1787GA Mutation in Prothrombin Gene: Rare but Strong Inherited Thrombophilia | Predrag Miljic | ![]() |
![]() |
|||
2-BR | Occlusive Thrombus Growth at High Shear Rates: Comparison of Whole Blood and Platelet Rich Plasma at Constant Pressure | Shunichi Kobayashi | ![]() |
![]() |
|||
3-LUP | Mixing Test Specific Cut-off is More Sensitive at Detecting in vitro Lupus Anticoagulant Inhibition than the Index of Circulating Anticoagulant with Multiple APTT and dRVVT Reagents | Osamu Kumano | ![]() |
![]() |
|||
3-VAS | CD146 Deficiency Leads to Accelerated Atherosclerosis in Mice through Upregulation of RANTES | Marie Nollet | ![]() |
![]() |
|||
3-FXIII | Visual Quantification of Fibrin Network Density | Joke Konings | ![]() |
![]() |
|||
3-AMC | Time-Dependent Decay of mRNA, Ribosomal RNA and Translation Activity in Platelets | Catherine Angénieux | ![]() |
![]() |
|||
3-BR | Shear-Dependent Red Blood Cell and Platelet Adhesion in Sickle Cell Disease | Erdem Kucukal | ![]() |
![]() |
|||
3-VWF | Role of the Arterial Pulsatility in the Modulation of von Willebrand Factor Multimerisation in an Animal Model of Continuous-Flow Left Ventricular Assist Support | Antoine Rauch | ![]() |
![]() |
|||
3-FVIII | FVIII-LRP1 Interaction affinity is Biased by FVIII Concentration | Michael Dockal | ![]() |
![]() |
|||
3-PP | Clinical and Pathogenetic Characterization of ETV6-Related Thrombocytopenia (ETV6-RT), an Inherited Thrombocytopenia (IT) Predisposing to Childhood Acute Lymphoblastic Leukemia (ALL) | Patrizia Noris | ![]() |
![]() |
|||
3-DIC | Laboratory Tests as Clues to Understand the Etiopathogenesis of Hemostatic Disturbances, Acute Kidney Injury and Mild Intravascular Hemolysis in Bothrops Envenomation | Marcelo Santoro | ![]() |
![]() |
|||
3-PLA | TFPI Levels and Correlation with Coagulation Parameters Based on Longitudinal Observations in Healthy Subjects | Jadranka Koehn | ![]() |
![]() |
|||
3-WOM | A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia | Leslie Skeith | ![]() |
![]() |
|||
3-PED | Increased Incidence and High Recurrence Rate of Venous Thromboembolism in Pediatric Oncology Patients in One Single Center over 25 Years | Irene Klaassen | ![]() |
![]() |
|||
4-FXI | Assessment of Small Molecular Weight Inhibitors of the Contact Pathway | Charlotte Bouckaert | ![]() |
![]() |
|||
4-FVIII | Variation in Baseline Factor VIII Concentration in Mild and Moderate Hemophilia A Patients Carrying the Same F8 Mutation | Janneke Loomans | ![]() |
![]() |
|||
4-DIC | Tissue Factor Initiated Thrombin Generation in Trauma Patient Plasma | Saulius Butenas | ![]() |
![]() |
|||
4-LUP | Evaluation of a New Formulation Dilute Russells Viper Venom Time for Detection of Lupus Anticoagulants | Gary Moore | ![]() |
![]() |
|||
4-CA | Genetic Dosing Algorithm Underestimates the Warfarin Dose Requirement among Patients Having Severe Thrombosis and/or Thrombophilia | Tuukka Helin | ![]() |
![]() |
|||
4-PED | Central Venous Catheters and Pediatric Thromboembolism, a Report from the Childrens Hospital Acquired Thrombosis (CHAT) Registry | Julie Jaffray | ![]() |
![]() |
|||
4-VAS | SGK1 Deficiency Protects from Neointima Formation via Reduction of Ca2-Dependent VSMC Migration | Sascha Geue | ![]() |
![]() |
|||
4-BR | Clot-Bound Thrombin under Venous Flow Conditions | Laura Haynes | ![]() |
![]() |
|||
4-PLA | Diagnostic Issues in Antithrombin, Protein C and Protein S Deficiency in the Hungarian Population: Experience of a Large Thrombosis Laboratory | Zsuzsanna Bereczky | ![]() |
![]() |
|||
4-AMC | Platelets Promote MMP-Dependent Plaque Destabilization Locally at the Site of Vascular Injury | Tom Mastenbroek | ![]() |
![]() |
|||
4-FXIII | Development and Evaluation of Total and Free Factor XIII-B Subunit ELISA Methods | Éva Katona | ![]() |
![]() |
|||
4-FIB | Recombinant Human ADAMTS13: First-in-Human Study Evaluating Pharmacokinetics, Safety and Tolerability in hTTP Patients | Jennifer Doralt | ![]() |
![]() |
|||
4-VWF | Possible Role of Protein Disulfide Isomerase PDIA in Mechanisms of von Willebrand Disease Type 3 | Maria A. Brehm | ![]() |
![]() |
|||
5-BR | Hemorheologic Bases for Thrombosis in Some Oncohematologic Diseases | Irina Kolesnikova | ![]() |
![]() |
|||
5-WOM | Hematologic Alterations in Patients Undergoing Controlled Ovarian Stimulation for in vitro Fertilization: A Prospective Observational Pilot Study | Maria T DeSancho | ![]() |
![]() |
|||
5-FXIII | FXIII Activity and Antigen during Pregancy | Carsten Detering | ![]() |
![]() |
|||
5-PRE | Acute Isolated Superficial-Vein Thrombosis is Associated with Substantial Comorbidity and History of Venous Thromboembolic Complications | Marie-Antoinette Sevestre | ![]() |
![]() |
|||
5-CA | Impact of Apixaban on the Dilute Russells Viper Venom Time: An Ex-vivo Study | Anne-Laure Sennesael | ![]() |
![]() |
|||
5-LUP | Lupus Patients with IgM Antiphospholipid Antibodies Are at Risk of Thrombocytopenia and Haemolytic Anemia: Pooled Results from Five Systematic Reviews and Meta-Analyses | Stéphane Zuily | ![]() |
![]() |
|||
5-VAS | Lysine-Rich Histones Induce Weibel-Palade Body Exocytosis through a Calcium, Caspase and Charge-Dependent Mechanism | Alison Michels | ![]() |
![]() |
|||
5-PP | Three-Dimensional Electron Microscopy Reveals New Details for Platelet Granule Exocytosis: Granule-to-Granule Versus Granule-to-Platelet Membrane Fusion | Anita Eckly | ![]() |
![]() |
|||
5-PLA | The Performance of Thrombin Generation Assays is Compromised at Reduced Plasma Levels of Antithrombin III | Michael Dockal | ![]() |
![]() |
|||
5-PED | Six Weeks Versus Three Months of Anticoagulant Treatment for Paediatric Central Venous Catheter-Related Venous Thromboembolism | Fiona Newall | ![]() |
![]() |
|||
5-FXI | Copurification of Polyphosphate with Nucleic Acids May Contribute to the Procoagulant Activity of DNA and RNA | Stephanie Smith | ![]() |
![]() |
|||
6-FXIII | Thromboelastography (TEG) and Thrombin Generation Assay (TGA) in Congenital Afibrinogenemia | VIRIDIANA CANO GARCIA | ![]() |
![]() |
|||
6-DIC | Coagulopathy Assessment in Severe Sepsis and Septic Shock Patients. An Observational Pilot Study | Ecaterina Scarlatescu | ![]() |
![]() |
|||
6-PED | Circumcision in Children with Haemophilia | HANDE KIZILOCAK | ![]() |
![]() |
|||
6-FXI | Correlation between the Thrombogenic Factor XIa and the Thrombus Score in the Venous Stasis Rabbit Model | CHARLES-EDOUARD LAURENT | ![]() |
![]() |
|||
6-AMC | Lack of Endothelial Nitric Oxide Synthase (eNOS) Induces a Pro-Thrombotic Phenotype in Mice | Stefania momi | ![]() |
![]() |
|||
6-LUP | Use of a Lupus Anticoagulant-Resistant Routine APTT Reagent as a Convenient Confirmatory Test | Osamu Kumano | ![]() |
![]() |
|||
6-BR | Thrombus Structure Change under Various Shear Rate, Using a Novel Microfluidic Device | Hideo Hirakata | ![]() |
![]() |
|||
6-PP | Blood Coagulation Factors Bound to Procoagulant Platelets Are Concentrated in Their Cap Structures to Promote Clotting | Nadezhda Podoplelova | ![]() |
![]() |
|||
6-WOM | Sociodemographic Characteristics of Women with Postpartum Hemorrhage: A Nationwide Inpatient Sample (NIS)-Based Analysis | Ariela Marshall | ![]() |
![]() |
|||
7-CA | Optimizing Therapy for Vitamin K Antagonist Induced Major Hemorrhage: A Systematic Review | Samuel Abegunde | ![]() |
![]() |
|||
7-HEM | Thromboembolic Events (TE) in Patients with Metastatic Non Small Cell lung Cancer (NSCLC) Treated with Platinum-based Chemotherapy | Victoria Eugenia Castellon Rubio | ![]() |
![]() |
|||
7-DIC | Coagulation Changes in Porcine Model of Sepsis Induced by Methicillin-Resistant Staphylococcus aureus (MRSA) Inoculation: Correlation between ROTEM and Routine Laboratory Tests | Jun Teruya | ![]() |
![]() |
|||
7-FXIII | Clinical and Molecular Characteristics of Patients Affected by Congenital Fibrinogen Deficiency | MUNIRA BORHANY | ![]() |
![]() |
|||
7-FXI | Procoagulant Activity in Immunoglobulin Products | Stella Williams | ![]() |
![]() |
|||
7-FIB | The Time Course of Plasma Procarboxypeptidase U (proCPU, proCPB2 or TAFI) in Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage is Not Associated with the Presence of Acute Coagulopathy | Dorien Leenaerts | ![]() |
![]() |
|||
7-PP | Heat Shock Protein 70 (Hsp70) Regulates Platelet Integrin Activation, Granule Secretion and Aggregation | Rachel Rigg | ![]() |
![]() |
|||
7-WOM | The Use of TEG/RoTEM in Pregnancy and Pregnancy Associated Complications: Results of a Worldwide Survey by the ISTH SSC for Womens Health Issues In Thrombosis and Haemostasis | Maha Othman | ![]() |
![]() |
|||
7-VAS | Gain-of-Function Mutation in TRPV4 Identified in Patients with Osteonecrosis of the Femoral Head | Chantal Seguin | ![]() |
![]() |
|||
7-FVIII | Immunological Profile of Previously Untreated Patients with Haemophilia A: Results from the HEMFIL Study | Letícia Lemos Jardim | ![]() |
![]() |
|||
7-PLA | Latex-Based Antithrombin Antigen Assays Can Give Falsely Reduced Levels | Peter Cooper | ![]() |
![]() |
|||
7-GEN | FVII Deficiency and Thrombosis, Coincidence or New Mechanism of Thrombophilia | Yacine Larfi | ![]() |
![]() |
|||
8-FXI | Investigation of Possible Correlation between Clinical and Laboratory Phenotype in Congenital FXI Deficiency: Results from a Single Center | Cristina Santoro | ![]() |
![]() |
|||
8-AMC | Hemostatic Disturbances and Oxidative Stress in Experimental Bothrops jararaca Envenomation: Modulation by the Natural Antioxidant Quercetin-3-Rutinoside (Rutin) | Marcelo Santoro | ![]() |
![]() |
|||
8-VWF | Platelet type von Willebrand Disease (PT-VWD) Posing Diagnostic and Therapeutic Challenges - Small Case Series | Maha Othman | ![]() |
![]() |
|||
8-FVIII | Thrombin Generation Assay (TGA) for Monitoring the Haemostatic Response in Patients with Hemophilia and Inhibitors on Immune Tolerance Induction (ITI): Preliminary in vitro and in vivo Results from the PredicTGA Study | Jordi Bozzo | ![]() |
![]() |
|||
8-WOM | Hyperfibrinolysis as One of the Reasons of Recurrent Fetal Loss in the Pregnant Women | Vladimir Sukhaniv | ![]() |
![]() |
|||
8-GEN | Identification of Molecular Defects in ITGA2B and ITGB3 Genes and Phenotypic Correlation in Pakistani Patients with Glanzmann Thrombasthenia | Muhammad Younus Jamal Siddiqi | ![]() |
![]() |
|||
8-PRE | Prevalence of Hemostatic Defects in Dengue Hemmorhagic Fever in a Tertiary Care Hospital in Karachi | Arshi Naz | ![]() |
![]() |
|||
8-FIB | Procarboxypeptidase U (proCPU, TAFI, proCPB2) in Cerebrospinal Fluid (CSF) in the Hyperacute Phase of Ischemic Stroke. | Joachim Mertens | ![]() |
![]() |
|||
8-FXIII | Automated Fibrin Structure Assay: Determination of Normal Range | MARTINAUD Christophe | ![]() |
![]() |
|||
8-LUP | IgG/IgM Antiphospholipid Antibodies Present in the Classification Criteria of the Antiphospholipid Syndrome: A Critical Review of Their Association with Thrombosis | Hilde Kelchtermans | ![]() |
![]() |
|||
8-HEM | Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia | Hélène Haguet | ![]() |
![]() |
|||
8-PED | The Incidence of Thrombosis and PTS in Children Two Years after Central Venous Catheter Placement | Fiona Newall | ![]() |
![]() |
|||
9-VAS | Soluble CD146 Priming Boosts Survival and Regenerative Properties of Endothelial Colony-Forming Cells | Marie Nollet | ![]() |
![]() |
|||
9-FIB | Local Hemostasis Changes and Endothelial Damage during Percutaneous Transcatheter Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation | Zsuzsa Bagoly | ![]() |
![]() |
|||
9-PED | Body Mass Index is Associated with Symptomatic Venous Thrombotic Events in Pediatric Oncology Patients: A Study from Maritimes, Canada | Ketan Kulkarni | ![]() |
![]() |
|||
9-PLA | Estimates of within-subject variation (CVI) of antithrombin, protein C, protein S free and activity, and Activated Protein C resistance (APCR) in pregnant and non-pregnant women. | Ann Helen Kristoffersen | ![]() |
![]() |
|||
9-FXIII | Characterization Of Phenotypic And Genotypic Expression Of Inherited Fibrinogen Coagulopathy In Pakistani Index Patients. | Tehmina Nafees Sonia Khan | ![]() |
![]() |
|||
9-HEM | Effects of Androgen Deprivation Therapy on Hypercoagulability in Prostate Cancer Patients - A Prospective Longitudinal Study | Maha Othman | ![]() |
![]() |
|||
9-PRE | Validation of the ISTH-SSC Bleeding Assessment Tool for the Diagnosis of Inherited Bleeding Disorders: Experience from a Tertiary Care Center in South India | Pagadalu Lokababu Ambika | ![]() |
![]() |
|||
9-PP | Risk Factors for Clopidogrel High on-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy | Dragana Backovic | ![]() |
![]() |
|||
9-CA | Prothrombin Conversion and Thrombin Inactivation in Patients Anticoagulated with Enoxaparin, Vitamin K Antagonists, and Rivaroxaban | Romy Kremers | ![]() |
![]() |
|||
9-LUP | Detection of Anti-Domain I Beta-2 Glycoprotein I Antibodies by Chemiluminescence Immunoassay in Antiphospholipid Syndrome Diagnosis | Ludek Slavik | ![]() |
![]() |
|||
9-VWF | Divergent Clinical and Laboratory Features of Acquired VWF Abnormalities in Patients with Pulmonary Hypertension versus High Shear Cardiac Lesions: Importance of the Procoagulant Property of VWF Multimers | Austin Christopher | ![]() |
![]() |
|||
9-WOM | Risk Assessment of Venous Thromboembolism (VTE) and Thromboprophylaxis in Women Hospitalized with Multiple Pregnancy | VENINA BARROS | ![]() |
![]() |
|||
10-LUP | Study of Anti-Cardiolipin (IgG/IgM aCL) and Anti-Beta2-Glycoprotein I (anti-2GPI) Antibodies in Patients with Ischemic Stroke (Ouest of Algeria) | KATIA ALLAL | ![]() |
![]() |
|||
10-AMC | Acquired von Willebrand Syndrome Evoked by Experimental Bothrops jararaca Envenomation | Marcelo Santoro | ![]() |
![]() |
|||
10-PED | Catheter-Related Arterial Thrombosis in Children: A Systematic Review | Mattia Rizzi | ![]() |
![]() |
|||
10-VWF | Severe Acquired von Willebrand Syndrome - A Single Centre Experience | Ingrid Hrachovinova | ![]() |
![]() |
|||
10-VAS | Activated Protein C (APC) Down Regulates Neutrophil Extracellular Traps (NETs): Potential Contributing Mechanism for Anti-Inflammatory and Antithrombotic Effects Of APC | Laura Healy | ![]() |
![]() |
|||
10-WOM | Inherited Thrombophilia Influences Localization and Extent of Pregnancy Related Deep Venous Thrombosis | Jelena Bodrozic | ![]() |
![]() |
|||
10-FIB | Thrombin Activatable Fibrinolytic Inhibitor (TAFI) Increases in the Plasma of Cancer Patients with Pro-Thrombotic Behavior | Juan-Carlos Murciano | ![]() |
![]() |
|||
10-FVIII | Evaluation of the Efficiency of Immunotolerance in Hemophilia A: Preliminary Results of the Brazilian Immmunotolerance Study | Pedro Henrique Fernandes do Carmo Las Casas | ![]() |
![]() |
|||
10-FXIII | Functional/Antigen Fibrinogen Ratio in Different Clinical Situations | Lucia Remotti | ![]() |
![]() |
|||
11-PED | Diagnostic Challenges and Clinical Implications in Children with Congenital Bleeding Disorders: A Developing Country Perspective | Sehar Khaliq | ![]() |
![]() |
|||
11-FIB | Combinatorial Therapy with C1 Esterase Inhibitor and Tranexamic Acid to Treat Hemorrhagic Shock | Veronika Bade | ![]() |
![]() |
|||
11-FXIII | Molecular Modelling of Identified Six Novel Missense Mutations in Pakistani Congenital Afibrinogenemia Patients | Tehmina Nafees Sonia Khan | ![]() |
![]() |
|||
11-LUP | Bone Marrow Necrosis and Pulmonary Thrombosis Associated with Antiphospholipid Syndrome | Huseyin Tokgoz | ![]() |
![]() |
|||
11-AMC | Patagonfibrase Modifies Protein Expression of Tissue Factor and Protein Disulfide Isomerase in Rat Skin | Marcelo Santoro | ![]() |
![]() |
|||
11-PP | Platelets Are Dispensable for Antibody-Mediated Transfusion-Related Acute Lung Injury in the Mouse | Béatrice Hechler | ![]() |
![]() |
|||
11-GEN | Identification of Two Novel Single Nucleotide Variants of the Complement Factor H (CFH) and Factor I (CFI) Genes in a Familial Form of Atypical Hemolytic Uremic Syndrome (aHUS) | Célia Dos Santos | ![]() |
![]() |
|||
11-CA | Accuracy of the Louzada Prediction Rule for Recurrent VTE in Cancer Patients on Rivaroxaban for the Treatment of Venous Thromboembolic Disease | Melissa Forgie | ![]() |
![]() |
|||
11-HEM | Diagnostic Performance of Hemostatic Biomarkers iin Cancer Patients | Elina Beleva | ![]() |
![]() |
|||
11-PRE | Inferior Vena Cava (IVC) Filters in Elderly Patients | Amihai Rottenstreich | ![]() |
![]() |
|||
11-VAS | Platelet-derived Factor V Is an Important Determinant of Ischemia-mediated Angiogenesis in a Mouse Hindlimb Model | Jianbo Wu | ![]() |
![]() |
|||
12-GEN | High Prevalence of VKORC13 (G9041A) Genetic Polymorphism in North Indians: A Study on Patients with Cardiac Disorders on Acenocoumarol | TUSHAR SEHGAL | ![]() |
![]() |
|||
12-WOM | Intravenous Iron Therapy in Non-Anemic Iron-Deficient Menstruating Adolescent Females with Fatigue | Ruchika Sharma | ![]() |
![]() |
|||
12-FIB | Effect of Elapsed Time between Plasma Separation and Processing on Fibrinolytic Activity | LUCIA REMOTTI | ![]() |
![]() |
|||
12-FVIII | ELISA Combined Chromogenic Assay (ECA) for Determination of Binding of PEGylated rFVIII to VWF | Michael Dockal | ![]() |
![]() |
|||
12-AMC | Algogenic Compounds Found in Rat Platelet Releasate | Marcelo Santoro | ![]() |
![]() |
|||
12-HEM | Evaluation of Thromboelastography (TEG) in Patients with Myeloproliferative Neoplasm (MPN): Platelet Count 600 Associated with Prothrombotic Parameters | Prahlad Ho | ![]() |
![]() |
|||
12-VAS | What is the best animal model to specifically target endothelial cells, without concomitant involvement of the hematopoietic lineage? | chloe James | ![]() |
![]() |
|||
12-PED | Risk Factors for Hospital-Associated Venous Thromboembolism in Critically-Ill Children with Cardiac Disease Undergoing Cardiothoracic Surgery or Cardiac Catheter-Based Therapeutic Intervention | Christie Atchison | ![]() |
![]() |
|||
12-CA | Early Changes in Medication Beliefs, Illness Perceptions and Anticoagulation Related Quality of Life in Patients Poorly Controlled on Vitamin-K Antagonists (VKAs) Switched to a Direct Oral Anticoagulant (DOAC) - Results from the SWITCHING Study | John Abdou | ![]() |
![]() |
|||
12-VWF | Functional Characterization of c.4876instgc and c2555ag VWF Gene Variants Identified Type 2 VWD Patient Population in Turkey | ergul berber | ![]() |
![]() |
|||
12-PLA | Identification and Significance of Anti-Mpl Autoantibody in Immune Thrombocytopenia | Fangmiao Jing | ![]() |
![]() |
|||
13-PED | Risk Factor Assignment Concordance and Clinical Care Guideline Compliance for Prevention of Pediatric Hospital Acquired-Venous Thromboembolism | Brian Branchford | ![]() |
![]() |
|||
13-HEM | Cancer, Chronic Kidney Disease and Thrombosis | Nicolas Janus | ![]() |
![]() |
|||
13-PP | Myr-RK6 Peptide Selectively Regulates Outside-in Signaling Transduction-Related Functions in Human Platelets | Zhangbiao Long | ![]() |
![]() |
|||
13-FIB | Longitudinal Analysis of Coagulant and Fibrinolytic Markers of Trauma Patients that Received Tranexamic Acid | Maria Cristina Bravo | ![]() |
![]() |
|||
13-WOM | Thromboelastography in Pregnancy: Establishing Reference Ranges in Third Trimester and Exploring Predictive Value for Postpartum Haemorrhage | Madeleine Malina | ![]() |
![]() |
|||
13-FVIII | The Patient Reported Outcome Burdens and Experiences (PROBE) Study - Phase 1 Results Show PROBE Study Methodology Feasible | Mark Skinner | ![]() |
![]() |
|||
13-PLA | Decreased miR-142-3p Promotes Survival of Hyperreactive B Cells by Targeting BAFF Receptor in Immune Thrombocytopenia | bin zuo | ![]() |
![]() |
|||
13-VWF | Inhibition of a Mouse-Human Chimeric Monoclonal Antibody to von Willebrand Factor on VWF A3-Collagen and VWF A1-Platelet Interactions | Yiming Zhao | ![]() |
![]() |
|||
13-CA | Analysis of Heparin Induced Thrombocytopenia Screening Tests in Critical Care Units | Osamah Khojah | ![]() |
![]() |
|||
14-VAS | Development of a Platform to Quantify the Colocalization of Neutrophil Extracellular DNA and Coagulation Factors using Immunofluorescence-Based Microscopy | Tiffany Chu | ![]() |
![]() |
|||
14-PP | Regulation of aIIb3 Signalling by the ITIM-Containing Receptor G6b-B | Yotis Senis | ![]() |
![]() |
|||
14-PRE | Ten Years of Cerebral Venous Thrombosis (CVT) in Northeast Melbourne, Australia: Male Gender and Presence of Myeloproliferative Neoplasm is Associated with Thrombotic Recurrence in Unprovoked Events | Prahlad Ho | ![]() |
![]() |
|||
14-CA | Post Analytical External Quality Assessment (EQA) for Computerised Decision Support Software (CDSS) Employed for INR Dosing | Dianne Kitchen | ![]() |
![]() |
|||
14-WOM | Screening of Female Family Members of von Willebrand Disease Patients: Utility of a Screening Tool | Claire Philipp | ![]() |
![]() |
|||
14-AMC | Aminoestrogen Diebud Decreases Circulating Microparticles | Mirthala Flores | ![]() |
![]() |
|||
14-PLA | The Outcome of Eltrombopag Therapy in Immune Thrombocytopenia: A Multicenter Study from Turkey | Gulsum Emel Pamuk | ![]() |
![]() |
|||
14-FVIII | The Relationship between Thrombin Generation and Spontaneous Bleeding for Hemophilia a Subjects in A-LONG and Extension Study | Yang Buyue | ![]() |
![]() |
|||
14-HEM | Thromboprophylaxis for Prevention of Venous Thromboembolism in Patients with Multiple Myeloma - A Systematic Review and Metaanalysis | Deepa Suryanarayan | ![]() |
![]() |
|||
14-VWF | Monoclonal Antibody that Binds to the C-Terminus of the A2 Domain of von Willebrand Factor Effectively Inhibits Platelet Adhesion to Collagen in a Force-Dependent Manner | Miguel Cruz | ![]() |
![]() |
|||
15-HEM | Risk Assessment of Venous Thromboembolism (VTE) and Thromboprophylaxis in Pregnant Women Hospitalized with Cancer | VENINA BARROS | ![]() |
![]() |
|||
15-VAS | Platelet Function and Microparticles Levels for Patients with Paroxysmal and Persistent Atrial Fibrillation Including during Acute Episodes | Line Pourtau | ![]() |
![]() |
|||
15-WOM | Coagulation Factor Changes during Pregnancy in Women with Inherited Bleeding Disorders | Angela Pereira | ![]() |
![]() |
|||
15-PP | ABO(H) Blood Group Expression Modifies Platelet Function | Eimear Dunne | ![]() |
![]() |
|||
15-VWF | Immunohistochemical Analysis of von Willebrand Factor Biodistribution in Liver Endothelial Cells | Laura Swystun | ![]() |
![]() |
|||
15-PRE | Performance of the STA-Liatest D-DI Plus for the Exclusion of Pulmonary Embolism in Emergency Departments using an Age-Adjusted Cut-Off | Laetitia Mauge | ![]() |
![]() |
|||
15-CA | External Quality Assurance Provision (EQA) for the Point of Care Xprecia Stride INR Device | Dianne Kitchen | ![]() |
![]() |
|||
15-PED | Paediatric Exposure to Intravenous Unfractionated Heparin | Fiona Newall | ![]() |
![]() |
|||
16-PRE | D-Dimer Assay Methods State-of-the Art from External Quality Assessment Results | Chantal Bon | ![]() |
![]() |
|||
16-CA | An Ultrasound-based Sensor for Real-time Monitoring of Heparin Anticoagulation Therapy | Jesse Jokerst | ![]() |
![]() |
|||
16-PED | Risk Factors Associated with Paediatric Thrombosis: A Five Years Retrospective Analysis in a Tertiary Care Hospital | Anila Rashid | ![]() |
![]() |
|||
16-WOM | Effect of Pregnancy on the Course of Immune Thrombocytopenia: A Retrospective Multicenter Study | Gulsum Emel Pamuk | ![]() |
![]() |
|||
16-PLA | Platelet Proteomics Profiling in Transfusion Adverse Events | Chaker ALOUI | ![]() |
![]() |
|||
16-PP | Fibrin Fibers from Cardiovascular Disease Patients on Aspirin Are More Extensible than Fibers from Healthy Individuals | Martin Guthold | ![]() |
![]() |
|||
16-FVIII | HLA Genotyping and Factor VIII Intron 22 Inversion in Children with Severe Haemophilia A: Relation to Factor VIII Inhibitor Development | HELEN PERGANTOU | ![]() |
![]() |
|||
17-VWF | Modification of ADAMTS13 Isoforms by Estradiol and Histamine Treatment | Célia Dos Santos | ![]() |
![]() |
|||
17-CA | Inclusion of a Heparin Neutralizer in the Plasma Diluent Confers Specificity to the FXa Direct Oral Anticoagulants Rivaroxaban, Apixaban, and Edoxaban in an Anti-Xa Chromogenic Assay | Duy Nguyen | ![]() |
![]() |
|||
17-PED | Endovascular Stents in Children | Gabriela Sciuccati | ![]() |
![]() |
|||
17-VAS | Biological Reference Materials to Standardize Measurements of Extracellular Vesicles | Pia Siljander | ![]() |
![]() |
|||
17-PP | The Impact of CYP2C19 2, 3, CYP4F2 3, Fibrinogen (C-148T) Genotype and Clinical Factors on Antiplatelet Effect during Induction of Ticagrelor and Aspirin Therapy | Vacis Tatarunas | ![]() |
![]() |
|||
17-PRE | Impact of Severe ADAMTS-13 Deficiency in Patients with Thrombotic Thrombocytopenic Purpura (TTP) on Recurrences | Laura Russo | ![]() |
![]() |
|||
17-PLA | Sensitive and Specific Functional Flow Cytometry Assay for the Rapid Diagnosis of Heparin-induced Thrombocytopenia and Thrombosis (HIT) | Michal Cipok | ![]() |
![]() |
|||
18-WOM | Proposed Trial: HYPATIA - A Prospective Randomised Controlled Trial of Hydroxychoroquine versus Placebo during Pregnancy in Women with Antiphospholipid Antibodies | Karen Schreiber | ![]() |
![]() |
|||
18-PP | Development and Upscaling of the Purification Process of Snake Venom Antiplatelet Agents | Bat-Erdene Jugder | ![]() |
![]() |
|||
18-PRE | Description of a New Prothrombin Gene Variant C20214T | Didier JAMBOU | ![]() |
![]() |
|||
18-CA | Influence of Factor VII on INR Determined with Recombinant Human and Tissue-Extract Thromboplastins | Joseph Biedermann | ![]() |
![]() |
|||
18-VAS | SIRT1 Deficiency in Endothelial Progenitor Cells Drives Pro-Senescent Microparticles Release through MKK6 Upregulation | Anne-Line CHATEAU | ![]() |
![]() |
|||
18-VWF | HemosIL VWF:RCo Werfen: A More Sensitive Reagent Than the Reference Technique for the Detection of Acquired von Willebrand Disease in Thrombocytosis Related to Myeloproliferative Neoplasms | chloe james | ![]() |
![]() |
|||
18-HEM | Short- and Long-Term Mortality after Pulmonary Embolism in Patients with and without Cancer | Ghazi Alotaibi | ![]() |
![]() |
|||
18-PLA | Comparison Head-to Head of Two Functional Assays in the Assessment of Heparin-Induced Thrombocytopenia | nadine ajzenberg | ![]() |
![]() |
|||
19-WOM | First Venous Thromboembolic Episodes in Women with Antithrombin Deficiency often associated with Oral Contraceptives or Pregnancy | Ariela Marshall | ![]() |
![]() |
|||
19-CA | The Effect of Dabigatran on Thrombin Generation in vitro | Willemijn Comuth | ![]() |
![]() |
|||
19-PRE | Venous Thromboembolism and Variants of FGG, F11 and AB0 in Czech Republic | Jan Kvasnicka | ![]() |
![]() |
|||
19-VWF | IMPACT OF PLATELET REACTIVITY ON INDIVIDUAL THROMBIN GENERATION IN PATIENTS WITH TYPE 3 AND TYPE 2 VON WILLEBRAND DISEASE | Timea Szanto | ![]() |
![]() |
|||
19-PLA | Improved Regulatory B-Cell in Adult Patients with Chronic Immune Thrombocytopenia Treated with Rapamycin | Lan Dau | ![]() |
![]() |
|||
19-HEM | Impedance Platelet Aggregometry for Surveillance of Ibrutinib Therapy in Chronic Lymphocytic Leukaemia | Will Thomas | ![]() |
![]() |
|||
19-PED | Prevalence and Characteristics of Epistaxis in Saudi Adolescents | Osamah Khojah | ![]() |
![]() |
|||
20-HEM | Platelet Transfusion Practices in Adult Surgical, Haematology and Oncology Patients | Anila Rashid | ![]() |
![]() |
|||
20-WOM | Evaluation of Protein C and Protein S Levels in Preeclamptic Women Seen in a Tertiary Institution in the Niger-Delta Region of Nigeria - Any Role in the Development of Preeclampsia? | Helen Okoye | ![]() |
![]() |
|||
20-PRE | High Sensitive LOCI Based F 12 Immunoassay for Quantification of Prothrombin Fragment 12 in Human Plasma Samples on the New INNOVANCE BCS LT System | Matthias Ehm | ![]() |
![]() |
|||
20-FVIII | Introduction of a Standardised Nijmegen - Bethesda Assay for the Detection and Quantification of FVIII Inhibitors | Tracey Noon | ![]() |
![]() |
|||
20-PP | Measurement of Platelet Serotonin Secretion by HPLC-Electrochemical Detection (ED) in a Clinical Hemostasis Laboratory: Sensitive, Specific and Accurate Assay for Diagnosing Platelet Secretion Defects and Heparin-Induced Thrombocytopenia | DIEGO MEZZANO | ![]() |
![]() |
|||
20-PLA | Slow Responders to Helicobacter pylori Eradication in Adult Japanese Patients with Immune Thrombocytopenia | Koji Miyazaki | ![]() |
![]() |
|||
20-CA | Commutability of Samples Used to Assess Assays for Direct Oral Anticoagulants (DOACS): Data from UK NEQAS for Blood Coagulation Multicentre Studies | Ian Jennings | ![]() |
![]() |
|||
21-PRE | Getting the Right Product to the Right Patient - Proposed Platelet Concentrate Screening to Improve Transfusion Outcome | Elisabeth Maurer-Spurej | ![]() |
![]() |
|||
21-VWF | Recombinant von Willebrand Factor Kinetics and Ultralarge Multimer Content in Severe von Willebrand Disease Patients | Miranda Chapman | ![]() |
![]() |
|||
21-CA | Is the Dilute Russells Viper Venom Time (DRVV-T) a Useful Assay for All Direct Oral Anticoagulants (DOACs)? | Miren Gabilondo | ![]() |
![]() |
|||
21-PLA | mTOR Staining in Bone Marrow and Spleen Tissues of Immune Thrombocytopenia Patients is Associated with Shorter Relapse-Free Survival | Gulsum Emel Pamuk | ![]() |
![]() |
|||
21-FVIII | Isolation of Antibodies that Differentiate Between Wild-Type FIX and the Padua Variant | Dirk Voelkel | ![]() |
![]() |
|||
21-VAS | Circulating Lipoprotein (a) Increases Aortic-Valve Calcification | Roberto Garrido | ![]() |
![]() |
|||
22-FVIII | Development and Application of a FIX-Specific Immunoassay to Monitor Hemophilia B Gene Therapy | Dirk Voelkel | ![]() |
![]() |
|||
22-WOM | High Factor VIII and Advanced Disease Are Associated with Risk of Recurrent Thrombosis in Women with Breast Cancer | Mirjana Kovac | ![]() |
![]() |
|||
22-PED | Frequency of Factor V Leiden and Prothrombin Mutation in Thrombotic Events in Children in North Moravian Region | Tomas Kuhn | ![]() |
![]() |
|||
22-HEM | The Hypercoagulable Profile of Patients with Myeloproliferative Neoplasms (MPN) as Detected by Whole Blood Rotational Thromboelastometry (ROTEM) | Cinzia Giaccherini | ![]() |
![]() |
|||
22-VWF | Phenotype Analysis Associated to p.Arg1315Cys (p.R1315C); the Value of DDAVP and VWFpp/VWF: Ag Ratio to Reach the Diagnosis | Alicia Blanco | ![]() |
![]() |
|||
22-PRE | Evaluation of the Risk Factors of Recurrence of Cerebral Venous Thrombosis | GISELLI SOUZA PIRES | ![]() |
![]() |
|||
22-PP22 | Platelet Calcium Flux Measurement by Flow Cytometry in Diluted Whole Blood | Barry Wilbourn | ![]() |
![]() |
|||
23-PLA | Can Heparin-Induced Multiple Electrode Aggregometry Improve Heparin-Induced -Thrombocytopenia (HIT) Diagnosis in the Intensive Care Unit Setting? A Prospective Study | Vasiliki Gkalea | ![]() |
![]() |
|||
23-CA | Consequences of Warfarin Suspension after Major Bleeding in a Cohort of Very Elderly Patients | Giacomo Zoppellaro | ![]() |
![]() |
|||
23-PRE | Does Thrombin Generation Test Predict the Outcome of Ischemic Stroke after Thrombolysis Treatment? | Zsuzsa Bagoly | ![]() |
![]() |
|||
23-PP | Role of Platelets in the Spatial Clot Growth Investigated with Reaction-Diffusion in vitro Experimental Mode | Anna Balandona | ![]() |
![]() |
|||
23-VWF | A Comparative Evaluation of a New Fully-Automated Assay for von Willebrand Factor Collagen Binding Activity to an Established Method | Francesca Stufano | ![]() |
![]() |
|||
23-HEM | Thrombosis in Myeloproliferative Neoplasia Associated with Different Coagulation Factor Polymorphisms | Ruta Dambrauskiene | ![]() |
![]() |
|||
24-VAS | Acidic Preconditioning Improves Endothelial Progenitor Cell Survival and Functionality under Inflammatory Conditions | Hebe Agustina Mena | ![]() |
![]() |
|||
24-CA | Assessment of Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Results from the TRIVET Study | Wendy Lim | ![]() |
![]() |
|||
24-WOM | Multicenter Registry on Thrombophilia and Pregnancy Loss: The OTTILIA Study | Elvira Grandone | ![]() |
![]() |
|||
24-PLA | Very Low Incidence of Heparin-Induced Thrombocytopenia in Pediatric Patients, Even in those with a High Pretest Probability | Takuma Maeda | ![]() |
![]() |
|||
24-HEM | Evaluation of Mean Platelet Volume as a Predictive Marker for Venous Thromboembolism in Patients Treated for Hodgkin Lymphoma | Joanna Rupa-Matysek | ![]() |
![]() |
|||
24-PP24 | Psoralen and Ultraviolet A Light Treatment Inhibits Activation of PI3K Dependent Effector Kinases by Disturbing Cell Membrane Packing | Hendrik Feys | ![]() |
![]() |
|||
24-FVIII | Benefit of the Study of F8 Gene Transcription by in vitro, in vivo and in silico Analysis in Hemophilia A | Catherine Costa | ![]() |
![]() |
|||
24-VWF | Von Willebrand Factor (VWF) Assays and the Diagnosis of von Willebrand Disease (VWD). Who Follows the Guidelines? | Ian Jennings | ![]() |
![]() |
|||
25-HEM | Risk Factors Assessment for Thrombosis in Patients with Cancer - Research Project of the Federal University of Minas Gerais | Pedro Henrique Fernandes do Carmo Las Casas | ![]() |
![]() |
|||
25-WOM | Management of Pregnancy in Patients with vWD | Vera Geierova | ![]() |
![]() |
|||
25-CA | Major Bleeding in Patients with Atrial Fibrillation on Non Vitamin K Antagonist Oral Anticoagulants - Data from Ljubljana Registry | Petra Sinigoj | ![]() |
![]() |
|||
25-FVIII | Method-Related Potency Issues of Modified Factor VIII Products | Daniels Sarah | ![]() |
![]() |
|||
25-PLA | A Rapid IgG Specific Lateral Flow Immunoassay Demonstrates Superior Diagnostic Performance to Platelet Factor 4/Heparin-Particle Gel Immunoassay in Screening for Heparin-Induced Thrombocytopenia | Noppacharn Uaprasert | ![]() |
![]() |
|||
25-VWF | Computer Modeling of Platelet Adhesion to a Surface with Grafted von Willebrand Factor Multimers | Aleksey Belyaev | ![]() |
![]() |
|||
26-WOM | The Dependence of Low Molecular Weight Heparin Efficacy (Tested by Anti Xa) on the Level of Antithrombin - A Case Report of a Pregnant Patient with Antithrombin Defficiency | Jana Prochazkova | ![]() |
![]() |
|||
26-FVIII | Individualizing Hemophilia Prophylaxis Using Thromboelastography (HIP TEG) | Guy Young | ![]() |
![]() |
|||
26-PRE | Sudden Onset Vision Loss as an Initial Manifestation of Elevated Serum Lipoprotein(a) Levels | Umran Caliskan | ![]() |
![]() |
|||
26-VWF | Effects of bilirubin on ADAMTS-13 Activity Measured with a FRETS rVWF73 Substrate-Based Fluorescent Assay | Arnaud Bonnefoy | ![]() |
![]() |
|||
26-CA | Patients Anticoagulation Knowledge (VKA) and INR Goal Attainment-Comparison 2014 and 2016 | Violeta Jovanoksa | ![]() |
![]() |
|||
27-WOM | Yes or No for Anticoagulant Thromboprophylaxis in Pregnant Women with Repeated Pregnancy Loss? | Lucia Stanciakova | ![]() |
![]() |
|||
27-PLA | Clinical Significance of Low CD4/CD8 Ratio in Patients with Immune Thrombocytopenic Purpura: A Single Centre Study | Samina Naz Mukry | ![]() |
![]() |
|||
27-PP | Functional and Molecular Characterization of an Inherited Abnormal Platelet Function Related to a New CalDAG-GEFI Protein Variant in an Argentinean family | Emilse Bermejo | ![]() |
![]() |
|||
27-CA | Can PT, aPTT and TT Reliably Be Used to Detect DOAC at Clinically Relevant Concentrations in Emergency Situations? Results from a 660-Patient Cohort Study | Virginie Siguret | ![]() |
![]() |
|||
28-CA | Effectiveness of Implementing an Extended INR Testing Interval for Stable Warfarin Patients: Results from the MAQI2 Collaborative of Anticoagulation Clinics | Geoffrey Barnes | ![]() |
![]() |
|||
28-FVIII | Product-Specific Calibration Standards Do Not Correct One-Stage Clotting Assay Discrepancies for Modified Recombinant FIX Molecules with Reagents that Significantly over- or under-Recover Labeled Potency | Yang Buyue | ![]() |
![]() |
|||
28-HEM | The Effectiveness of Laboratory Tests in Haemostasis Assessment in Children with Thrombosis with Solid Tumors and Haematologic Malignancies | Natalia Korotina | ![]() |
![]() |
|||
28-WOM | The Role of LMWH to Improve the Pregnancy Outcome | Maria Hulikova | ![]() |
![]() |
|||
28-VWF | Ferritin Promotes Secretion of von Willebrand Factor (VWF) from Endothelial Cells: a Potential Mechanistic Implication for Patients with Pathological Immune Activation | Dalia Bashir | ![]() |
![]() |
|||
28-PLA | An Activating Mutation of DIAPH1 Encoding Rho-Effector Diaphanous-Related Formin-1 Causes Inherited Macrothrombocytopenia Associated with Sensorineural Hearing Loss in a French Family | Paquita Nurden | ![]() |
![]() |
|||
29-PP | Value of Whole Blood Impedance Aggregometry in the Diagnosis of Inherited Platelet Function Disorders | Marie Line Moussalli | ![]() |
![]() |
|||
29-PLA | Increased Platelet Expression in HIV Positive Treatment Naive Patients Does Not Correlate with CD4 Count | RAEL ONJULA | ![]() |
![]() |
|||
29-FVIII | Bleeding Scores in Hemophilia: Are They Useful in Predicting Severity and Clinical Outcomes | MUNIRA BORHANY | ![]() |
![]() |
|||
29-VWF | Understanding Normal: Baseline VWF Characteristics in Normal BOECs | Mackenzie Bowman | ![]() |
![]() |
|||
29-PRE | Mean Platelet Volume as a Biomarker of Disease Activity in Polymyalgia Rheumatica | Gulsum Emel Pamuk | ![]() |
![]() |
|||
30-PP | Diagnostic value of a Flow Cytometry Based Platelet Function Test Compared with Light Transmission Aggregometry in Patients with Unknown Bleeding Disorders | Ivar van Asten | ![]() |
![]() |
|||
30-VWF | ADAMTS13 in Chronic Liver Diseases: Data from the Developing World | Priyanka Saxena | ![]() |
![]() |
|||
30-CA | Estimation of Rivaroxaban Plasma Concentrations in the Perioperative Setting with or without Heparin Bridging: An Ex vivo Study Using Dedicated Chromogenic Assays | Franois Mullier | ![]() |
![]() |
|||
31-CA | Self-testing and Self-management of Oral Anticoagulation Therapy (OAT) in Children with Congenital Heart Disease (CHD). From the Bedside to Home. A Pilot Study in Spain | Veronica Pons | ![]() |
![]() |
|||
31-PP | Antiplatelet Aggregation Activity of Two Schiff Base Ligands Derived from 3-Hydroxy-2-Naphthaldehyde and Their Corresponding Copper(II) Complexes | AURORA DE LA PEÑA | ![]() |
![]() |
|||
31-FVIII | Thrombin Generation Does Not Correlate with Disease Severity but May Be Predictive of Response to Treatment in Patients with Severe Hemophilia A | Ruchika Sharma | ![]() |
![]() |
|||
31-VWF | Bleeding Score in Type 1 von Willebrand vWD Patients using the ISTH-BAT Questionnaire | ANIL PATHARE | ![]() |
![]() |
|||
32-PRE | Red Cell Distribution Width is Associated with Atherosclerotic Cardiovascular Mortality in Gouty Arthritis | Gulsum Emel Pamuk | ![]() |
![]() |
|||
32-PP | TPO agonist for the Treatment of May Hegglin Anomaly Deriving from MYH9 Mutation | Nadia SARI HASSOUN | ![]() |
![]() |
|||
32-FVIII | Prophylaxis with Factor-Eight-Inhibitor-by-Passing-Activity Three Days a Week Results in Safe and Effective Haemostasis in Children with Haemophilia A with Inhibitors | Mark Belletrutti | ![]() |
![]() |
|||
32-VWF | Correlation of Phenotypic and Genotypic Expression of VWD Type I and II in Pakistani Patients | SHARIQ AHMED | ![]() |
![]() |
|||
33-FVIII | Results from a World-Wide Field Study of FVIII Activity Assay Variability of BAX 855, the PEGlylated form of rFVIII ADVATE, in Clinical Hemostasis Laboratories | peter Turecek | ![]() |
![]() |
|||
33-PP | In vitro Antiplatelet Activity of Anthocyanin | Almottesembellah Gaiz | ![]() |
![]() |
|||
33-VWF | Comparison between VWF:RCo and VWF:CB in a 2B VWD Cohort | Adriana Woods | ![]() |
![]() |
|||
34-PP | Sticky Platelet Syndrome - Questionable or Independent Risk Factor for Thrombosis? | Jan Stasko | ![]() |
![]() |
|||
34-VWF | False Negative and False Positive Responses in Ristocetin-Induced Platelet Aggregation Mixing Studies | Juan Pablo Frontroth | ![]() |
![]() |
|||
34-CA | Evaluation of the CP3000 Coagulation Analyzer | An Stroobants | ![]() |
![]() |
|||
35-PP | An Atypical IgM Antibody that Induces Integrin aIIb3 Activation and Glanzmann Thrombasthenia-Like Phenotype Associated with Macrothrombocytopenia | ZERYAEHY EARHYAETH | ![]() |
![]() |
|||
35-FVIII | Multi-National Survey of FVIII Activity Assay Practice | peter Turecek | ![]() |
![]() |
|||
35-CA | Evaluation of the Intra-, Inter- and Day-to Day Variability of the ROTEM | Petra Jilma-Stohlawetz | ![]() |
![]() |
|||
36-PP | Membrane Microvesicles Generated in Stored Blood Components | EMMANUEL HERNANDEZ | ![]() |
![]() |
|||
36-FVIII | Effects of Haemolysis, Icterus and Lipaemia on Coagulation Tests as Performed Using Mechanical Viscosity Based Endpoint Detection | Anita Woolley | ![]() |
![]() |
|||
38-CA | A Performance Evaluation of a Novel Human Recombinant Tissue Factor Prothrombin Time Reagent | Chris Gardiner | ![]() |
![]() |
|||
38-PP | Aspirin Response in Myeloproliferative Patients using Multiplate Aggregometry | Bethan Myers | ![]() |
![]() |
|||
39-PP | Influence of Exercise Intensity on Platelet Aggregation in Patients with Heart Disease. | Hitoshi Adachi | ![]() |
![]() |
|||
39-FVIII | Diagnosis and Management of Acquired Haemophilia - Single Centre Experience | Peter Salaj | ![]() |
![]() |
|||
39-CA | The Control of Heparin Treatment with Global Hemostasis Assays: A Sensitivity Analysis | Anna Balandona | ![]() |
![]() |
|||
40-CA | Evaluation of Laboratoricaly Monitored Efficiency of New Oral Anticoagulants Rivaroksaban and Dabigatran | Marija ega | ![]() |
![]() |
|||
40-PP | Platelet Function Diorders Diagnosis Using Flow Cytometry: About 19 Families in Algeria | BOUKERB HOUDA | ![]() |
![]() |
|||
40-FVIII | Turkish Experience with Low Dose of Immun Tolerance Treatment for Inhibitor Patients | KAAN KAVAKLI | ![]() |
![]() |
|||
41-PP | Predictors of the Secondary Aspirin Resistance in Patients with Coronary Artery Disease over 60 (according to the 10-year follow-up) | Viktoriia Zharinova | ![]() |
![]() |
|||
42-CA | Distinct Effects of Apixaban and Rivaroxaban on Thrombin Generation and Coagulation during Recovery after Total Hip Arthroplasty | Tuukka Helin | ![]() |
![]() |
|||
42-FVIII | Haemophilia A and Immune Tolerance Induction - Our First Experiences | Marian Fedor | ![]() |
![]() |
|||
43-CA | Performance of a New Chromogenic Apixaban Assay on Automated Analyzers | Zhenghua Cao | ![]() |
![]() |
|||
44-FVIII | Factor VIII Effect and Sensitivity Vary Depending on Trigger in Thrombin Generation Assays with Plasma from Patients with Hemophilia A | Michael Dockal | ![]() |
![]() |
|||
44-CA | Safety and Efficacy of Dabigatran Compared with Warfarin in Patients with Acute Venous Thromboembolism Enrolled in RE-COVER/ RE-COVER II in Western Europe | Michelle Souter | ![]() |
![]() |
|||
45-CA | Efficacy and Safety of Dabigatran versus Warfarin for the Treatment of Acute Venous Thromboembolism: a Pooled Analysis of 90-Day Data from RE-COVER and RE-COVER II | Michelle Souter | ![]() |
![]() |
|||
46-CA | Application of Basic and Special Coagulation Tests for Measuring Rivaroxaban Activity | Aránzazu García Raso | ![]() |
![]() |
|||
46-FVIII | A Simple Predictive Model of Thrombin Generation for the Individualization of Hemophilic Treatment | Pierre Chelle | ![]() |
![]() |
|||
47-FVIII | Effectiveness of Heat Inactivation in Removing Residual FVIII Interference in the FVIII Nijmegen Bethesda Assay | Mary Robinson | ![]() |
![]() |
|||
48-CA | Reasons and consequences of Vitamin K Antagonists (VKA) Discontinuation in Very Elderly Patients with Non Valvular Atrial Fibrillation (NVAF). An Inception Cohort Study | Giacomo Zoppellaro | ![]() |
![]() |
|||
48-FVIII | Haemolysis Effects on Clotting Factor and Thrombotic Assay Results using Matched Haemolysed and Non-Haemolysed Patient Samples and Two Artificial Haemolysis Mechanisms | Paula Brown | ![]() |
![]() |
|||
49-FVIII | Application of Rox Factor IX on the ACL TOP 700 | Pia Bryngelhed | ![]() |
![]() |
|||
49-CA | The Frequency of Gene Polymorphism among Patients with Hemorrhagic Complications Connected with Warfarin Therapy | Olga Philippova | ![]() |
![]() |
|||
50-CA | Prescribing Errors with New Oral Anticoagulants at a Regional Base Hospital in NSW, Australia | David Glendinning | ![]() |
![]() |
|||
50-FVIII | The Utility of ISTH BAT in Assessing the Bleeding Phenotype in Patients with FV Deficiency | MUNIRA BORHANY | ![]() |
![]() |
|||
52-FVIII | Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions and after FIX Concentrate Administration | Cristina Santoro | ![]() |
![]() |
|||
52-CA | Warfarin as a New Oral Anticoagulant Agent? | Pall Onundarson | ![]() |
![]() |
|||
53-FVIII | The Development of Arterial Thrombosis in Hemophilia A - Unusual Coincidence ? Case Report and Review of the Literature | Lucia Stanciakova | ![]() |
![]() |
|||
54-CA | Matrix Effect of Commercially Available Direct Oral Anticoagulant Standards: A Look through the Limits and the Need for Standardization of Current Calibrators | Jonathan Douxfils | ![]() |
![]() |
|||
54-FVIII | Managing Hemophilia Treatment in Algeria, the Experience of Constantine | SIHEM KEBAILI | ![]() |
![]() |
|||
55-FVIII | Epidemiological Study of Hemophilia at Tlemcen University Hospital (Algeria) | BERBER BAHYA | ![]() |
![]() |
|||
56-FVIII | Potency Estimates for Recombinant Factor IX in the One-Stage Clotting Assay Are Influenced by More than Just Choice of APTT Reagent | Helen Wilmot | ![]() |
![]() |
|||
56-CA | Acute Ischemic Stroke after Administration of Kcentra for Apixaban-associated Intracranial Hemorrhage | Navdeep Lail | ![]() |
![]() |
|||
57-CA | Unusual Site Thrombosis - Epidemiology and Outcome | PRAVAS CHANDRA MISHRA | ![]() |
![]() |
|||
58-FVIII | Inherited Bleeding Disorders: An Experience from a Tertiary Care Centre in South India with Emphasis on an Algorithmic Approach to Diagnosis | Rakhee Kar | ![]() |
![]() |
|||
58-CA | A Comparative Study Using Four Different Clot Detection Methods for INR Monitoring in Patients on Vitamin K Antagonist Treatment | Alex Gatt | ![]() |
![]() |
|||
59-CA | Warfarin Dose Assessment Every 4 Weeks versus Every 6 to 8 Weeks in Patients with Stable International Normalized Ratios: A Retrospective Study | Siavash Piran | ![]() |
![]() |
|||
59-FVIII | A New Comprehensive Screening Program for Optimizing the Diagnosis of Coagulopathies in a Tertiary Hospital | VERONICA PONS | ![]() |
![]() |
|||
60-CA | Development of an INRRIVA on Plasma Samples of Patients on Rivaroxaban | James Zhang | ![]() |
![]() |
|||
61-FVIII | Distraction Arthroplasty in Patient with Hemophilic Arthropathy (A Case Report) | Maria Hulikova | ![]() |
![]() |
|||
62-CA | A Different Clinical Profile of DOAC-Treated Patients: Results from the Real Life Cohort Study | Miren Gabilondo | ![]() |
![]() |
|||
63-CA | Rivaroxaban Therapy for Patients with Pulmonary Embolism in Real World: A Prospective, Single Center, Open-label Observation Study | Tian-Yu Lian | ![]() |
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|